About event
Telik was a life science start-up engaged in high-risk drug invention. In this webinar, Steve will tell the 21- year tale of the birth, rise and demise of Telik, which at one point, was valued at ~$1.5 billon USD. This is the story of how it all unfolded from the beginning then faded away into the vast landscape of bygone failed biotech companies.
Ultimately, Telik vanished into nothingness without a trace, except in the memories of the handful of employees who experienced the grand adventure of a lifetime.
Steven Schow, PhD, Adjunct Professor Stanford University of Medicine
Steve was the Vice President of Research and Development at Telik, Inc. until his retirement in 2014. He has more than 45 years of pharmaceutical, biotech and agrichemical industrial R&D experience. He holds a doctorate in chemistry from the University of California at San Diego and completed postdoctoral training at the University of California at Los Angeles and the University of Pennsylvania. He has been a SPARK advisor since 2008 where he provides drug development mentoring to SPARK-teams, including SPARK Global teams upon request. He also furnishes business development guidance to those projects selected for annual VC-Events, such as JP Morgan, BIO and BIO Investor Forum.
